These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38636490)

  • 1. [Towards a Better understanding of Persisting Perceptual Disturbances following the use of Classic Psychedelics.].
    Avram M; Herwig U; Borgwardt S; Majić T
    Fortschr Neurol Psychiatr; 2024 Apr; 92(4):118-120. PubMed ID: 38636490
    [No Abstract]   [Full Text] [Related]  

  • 2. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment.
    Doyle MA; Ling S; Lui LMW; Fragnelli P; Teopiz KM; Ho R; Di Vincenzo JD; Rosenblat JD; Gillissie ES; Nogo D; Ceban F; Jawad MY; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):733-743. PubMed ID: 35426769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
    Johnson MW
    Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of classic psychedelics among adults: a Danish online survey study.
    Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A
    Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms.
    Tariq R
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):94-109. PubMed ID: 35319407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trip of a lifetime: hallucinogen persisting perceptual disorder.
    Anderson L; Lake H; Walterfang M
    Australas Psychiatry; 2018 Feb; 26(1):11-12. PubMed ID: 28836813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding Light on Classic Psychedelics and Self-Harm.
    Grossman DH; Hendricks PS
    J Clin Psychiatry; 2022 Jan; 83(2):. PubMed ID: 35044729
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerations in assessing the abuse potential of psychedelics during drug development.
    Calderon SN; Bonson KR; Reissig CJ; Lloyd JM; Galati S; Chiapperino D
    Neuropharmacology; 2023 Feb; 224():109352. PubMed ID: 36455646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Applications of Classic Hallucinogens.
    Bogenschutz MP; Ross S
    Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.
    Dourron HM; Strauss C; Hendricks PS
    Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who takes the trip? Personality and hallucinogen use among college students and adolescents.
    Parnes JE; Kentopp SD; Conner BT; Rebecca RA
    Drug Alcohol Depend; 2020 Dec; 217():108263. PubMed ID: 32932162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
    Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
    Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinogens: an update.
    Halpern JH
    Curr Psychiatry Rep; 2003 Oct; 5(5):347-54. PubMed ID: 13678554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.
    G Lerner A; Goodman C; Bor O; Lev-Ran S
    Isr J Psychiatry Relat Sci; 2014; 51(4):277-80. PubMed ID: 25841224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelics as a novel approach to treating autoimmune conditions.
    Thompson C; Szabo A
    Immunol Lett; 2020 Dec; 228():45-54. PubMed ID: 33035575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effects of classic psychedelics on memory in humans.
    Healy CJ
    Psychopharmacology (Berl); 2021 Mar; 238(3):639-653. PubMed ID: 33420592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.
    Calleja-Conde J; Morales-García JA; Echeverry-Alzate V; Bühler KM; Giné E; López-Moreno JA
    Addict Biol; 2022 Nov; 27(6):e13229. PubMed ID: 36301215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pain and psychedelics: a review and proposed mechanism of action.
    Castellanos JP; Woolley C; Bruno KA; Zeidan F; Halberstadt A; Furnish T
    Reg Anesth Pain Med; 2020 Jul; 45(7):486-494. PubMed ID: 32371500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
    Espiard ML; Lecardeur L; Abadie P; Halbecq I; Dollfus S
    Eur Psychiatry; 2005 Aug; 20(5-6):458-60. PubMed ID: 15963699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.